Dapagliflozin as add-on to metformin may reduce T2DM burden in China

  • PDF / 167,363 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 58 Downloads / 212 Views

DOWNLOAD

REPORT

173-5503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860

1

Data Loading...

Recommend Documents
Dapagliflozin/lidocaine/metformin

156 44 168KB

Dapagliflozin cost-saving alternative to DPP-4 inhibitors in T2DM

179 74 166KB

The Disease Burden Due to Epilepsy in Rural China

153 71 57MB

Can tobacco tax increases reduce smoking burden in Latin America?

152 45 163KB

Dapagliflozin

137 57 167KB

Atorvastatin cost effective in T2DM

163 57 182KB

Dapagliflozin/empagliflozin

145 83 167KB

Transcending false dichotomies and diagnostic silos to reduce disease burden in mental disorders

139 87 602KB

Canagliflozin/dapagliflozin

168 110 165KB

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real

131 56 1MB

Metformin

169 8 148KB

Metformin

140 18 165KB